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8 wild type strains of Bifidobacterium pseudocatenulatum and 4 commercial strains 
(B. pseudocatenulatum JCM 1200, B. infantis ATCC 15698, B. breve ATCC 26720 
and B. longum BB536) were screened for inulinase activity on modified PY-0 and 
PY-I agar. Wild type B. pseudocatenulatum F117 and reference B. 
pseudocatenulatum JCM 1200 were determined to have the highest inulinase 
activity. This activity was apparently higher on PY-0 agar in comparison to PY-I 
agar. In batch cultivation, growth of B. pseudocatenulatum F 1 17 was enhanced in 
PY-0 medium (0.38 h-' and 2.64 x lo8 cfulrnL), compared to PY-G (0.48 h-' and 
5.45 x lo8 cfulrnL) and PY-I medium (0.20 h" and 1.70 x lo8 cfulmL) from the 
respective, initial specific growth rate and maximum growth. Acetic, lactic and 
formic acid production was also found to be relatively higher in PY-0 medium 
(38.60 mM; 37.48 mM; 7.37 mM) compared to PY-G medium (11.95 mM; 22.77 
mM; 5.91 mM) or PY-I medium (12.34 mM; 19.73 mM; 0 mM). In therapeutic 
study, the antagonistic effect against E. coli V157 by B. pseudocatenulatum F117 
was contributed by pH lowering of the growth medium. This effect was especially 
intensified at pH below 5.0. Antagonistic effect found in PY-0 medium was greater 
compared to that of PY-G medium. The kinetics of antagonistic effect could be 
divided into two apparent phases. It was the condition before (first phase) and after 
(second phase) B. pseudocatenulatum F117 to achieve the maximum growth (lo9 
cfu/mL), with relatively intense antagonistic effect at second phase. Organic acid 
was highly produced at second phase (PY-G medium: 45.5728.99 mM; PY-0 
medium: 61.542 1 1.92 mM) rather than first phase (PY-G medium: 25.59k3.16; PY- 
0 medium: 30.46k7.21 rnM) implicative of the importance of probiotic 
concentration for effective antagonism. Oligohctose was found to be able to 
stimulate the growth of B. pseudocatenulatum F117 and consequently shorten the 
time for the maximum growth to achieve, from 18 hr in PY-G medium to 12 hr in 
PY-0 medium. Besides, lactic acid production was initiated 6 hr earlier in PY-0 
medium than to PY-G medium, which could be an added inhibitory advantage. With 
low bifidobacteria dose (10' cfu/mL), the antagonistic effect displayed was quite 
identical to a higher dose (lo8 cWmL) employed. B. pseudocatenulatum F1l7 was 
found to obtain the maximum growth in 18 hr for the both trial doses in either 
growth medium. In prophylactic study, PY-0 medium could not be observed to 
further enhance the antagonistic effect in PY-G medium. E. coli V157 (1 o8 cfu/mL) 
was unable to sustain and multiply to a higher population but decreased in numbers 
in either growth mediums. Finally, a higher oligofructose concentration (1.0 %) was 
shown to dramatically improve the antagonistic effect as compared to the lower 
concentration (0.5 %) used, in both therapeutic and prophylactic study. This effect 
was again due to an even higher amount of organic acids produced. 
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8 stren liar Bijidobacterium pseudocatenulatum dan 4 stren komersial (B. 
pseudocatenulatum JCM 1200, B. infantis ATCC 15698, B. breve ATCC 26720 dan 
B. longum BB536) disaring untuk aktiviti inulinase ke atas agar gubahan PY-0 dan 
PY-I. Stren liar B. pseudocatenulatum F117 dan kawalan B. pseudocatenulatum JCM 
1200 didapati memperoleh aktiviti inulinase yang tertinggi. Aktiviti tersebut adalah 
lebih ketara tinggi pada agar PY-0 dibanding dengan agar PY-I. Dalam 
pengkulturan tertutup, pertumbuhan B. pseudocatenulatum F117 dipertingkatkan 
dalam media PY-0 (0.38 h-' and 2.64 x 10' cfulmL,) berbanding dengan media PY-G 
(0.48 h" and 5.45 x 10' cfulmL) dan PY-I (0.20 h" and 1.70 x 10' cfulmL,) dari segi 
kadar pertumbuhan spesifik awal dan pertumbuhan maksirnurn masing-masing. 
Penghasilan asid asitik, laktik dan formik juga didapati lebih tinggi dalam media PY- 
0 (38.60 rnM; 37.48 mM; 7.37 rnM) dibanding dengan media PY-G (11.95 mM; 
22.77 mM; 5.91 rnM) mahupun media PY-I (12.34 mM; 19.73 mM; 0 mM). Dalam 
kajian pemulihan, kesan antagonistik terhadap E. coli V157 daripada B. 
pseudocatenulatum F117 adalah disebabkan oleh p e n m a n  pH media pertumbuhan. 
Kesan ini menjadi lebih hebat di bawah pH 5.0. Kesan antagonistik di dalam media 
PY-0 adalah lebih hebat dibandingkan di dalam media PY-G. Kinetics dalam kesan 
antagonistik dapat dibahagikan kepada dua fasa yang jelas. hi adalah keadaan 
sebelum (fasa pertama) dan selepas (fasa kedua) B. pseudocatenulatum F 1 17 
mencapai pertumbuhan maksimumnya (lo9 cfulmL), di mana kesan antagonistik 
yang lebih hebat berlaku pada fasa yang kedua. Asid organik banyak dihasilkan pada 
fasa kedua (media PY-G: 45.57k8.99 mM; media PY-0: 61.54k11.92 mM) 
berbanding dengan fasa pertama (media PY-G: 25.59+3.16; media PY-0: 
30.46k7.21 mM), justerunya mengimplikasikan kepentingan kandungan probiotik 
untuk antagonisma yang berkesan. Oligofivlktosa didapati merangsangkan 
perturnbuhan B. pseudocatenulatum F 1 17 dan seterusnya mengurangkan tempoh 
untuk mencapai pertumbuhan maksimumnya (lo9 cfulmL), daripada 18 j dalam 
media PY-G kepada 12 j dalam media PY-0. Di samping itu, penghasilan asid laktik 
bermula 6 j lebih awal dalam media PY-0 daripada dalam media PY-G, 
kemungkinan besar menjadi kebaikan tarnbahan faktor perencatan. Pada dos 
bifidobakteria yang rendah (10' c fu ld) ,  kesan antagonistik yang dihasilkan adalah 
agak sarna dengan dos yang tinggi (lo8 cfulmL) digunakan. B. pseudocatenulatum 
F117 didapati mencapai pertumbuhan maksimurn dalam 18 j untuk kedua-dua dos 
dalam mana-mana media pertumbuhan. Dalam kajian pencegahan, media PY-0 
didapati tidak meningkatkan kesan antagonistik lagi sepertirnana yang diperhatikan 
dalam media PY-G. E. coli (lo8 cfulmL) tidak dapat mengekal mahupun 
membangun kepada populasi yang lebih tinggi tetapi berkurangan dalam 
bilangannya. Akhirnya, kepekatan oligofiuktosa yang tinggi (1 %) didapati 
menghasilkan kesan antagonistik yang lebih hebat daripda kepekatan rendahnya (0.5 
%) dalam kedua-duanya kajian pemulihan dan pencegahan. Kesan ini disebabkan 
oleh penghasilan asid organik yang lebih tinggi lagi. 
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CHAPTER 1 
INTRODUCTION 
Gut health is currently getting much attention among researchers and public. 
This is mainly because many of the physical health problems were found closely 
related to the improper functionality of gut. Over the years, study of the 
microbiological system in the gut has slowly uncovered the general effects brought 
to the host. Evolved from birth, this group of microorganism has adapted and 
changed according to the maturity of gut, which make them present as one entity in 
the so-called "symbiosis" relationship. This is the most important fact that many 
researchers have been neglecting so far, by putting less attention to the biochemistry 
of these microorganisms. These organisms and their metabolic activities are not inert 
to the human host and have both positive and negative impacts on health. The 
balance of this ecosystem is dynamic and may be altered by several factors such as 
aging, medication, stress, diet, and some other environmental factors (Conway, 
2001). The maintenance of a community of bacteria, which contains a predominance 
of beneficial species and minimal putrefactive processes, is believed to be important 
for maintaining intestinal health. 
The concept of probiotic appears when effort is made to modifL or alter the 
composition of the microfloras in the gut to a remedial one by directly introducing 
the biologically important beneficial microorganism (Gibson and Roberfioid, 1995). 
Most of the attempt microorganisms are of human origin and largely represented by 
Bijidobacterium and Lactobacilli (Silvi et al., 2003). These microorganisms are 
found to be the predominant gut floras in the breastfed infants and also in healthy 
adults. The beneficial influences of probiotic on human gut floras include factors 
such as antagonistic effects, competition and immune effects. Improved resistance to 
pathogen offers the most promise for development of efficacious probiotics. The use 
of probiotic bacterial cultures stimulates the growth of preferred microorganism, 
crowds out potentially harmful bacteria and reinforces the body's natural defense 
mechanisms (Conway, 2001). 
Currently, the prebiotic strategy is proposed as an alternative mode to 
improve the well being of gut. This is the application of indigestible food ingredient 
that has impact on the metabolism of intestinal microorganisms (Holzapfel and 
Schillinger, 2002). In the scientific literature, most of the data on prebiotic effect 
deals with inulin and fructooligosaccharides, and a range of commercial products 
have been available for many years. First the majority of data were produced on the 
ability of these carbohydrates to increase the amount of bifidobacteria in faeces. 
During recent years, more emphasis has been put on physiological functions, such as 
gut function, colon cancer biomarkers, calcium absorption and lipid metabolism 
(Puupponen-Pimia et al., 2002). 
Due to the potential synergy between probiotic and prebiotic, foods 
containing a combination of these ingredients are often referred to as synbiotic 
(Gibson and Roberfioid, 1995). Prebiotic might influence the growth and survival of 
the probiotic and starter in fermented dairy products. One may also expect the 
prebiotic to serve as a preliminary growth substance while introducing a biologically 
important probiotic into the gut. This is especially important in view of the weakness 
of probiotic surviving through gastrointestinal tract to reach an allocated site such as 
in the small and large bowel. Nonetheless, endeavors have been made to improve the 
competency of the probiotic consumed. Some researchers suggested having pre- 
adaptation of the probiotic to prebiotic prior to consumption. This might post 
competitive advantage for the probiotic if it is consumed concurrently with the 
prebiotic (Conway, 2001). On the other hand, the correct pair of probiotic and 
prebiotic is designed to ensure a successful establishment of probiotic in the gut 
among the presence of the large microbial assemblage (Fooks and Gibson, 2002). 
This is true when the substrate affinity of probiotic, for example Bijidobacterium, is 
varied among species and strains. Therefore, in applying the principle of synbiotic, 
besides proper strains selection for a characteristic probiotic, one has to take into 
consideration the substrate affinity of these probiotic as well. Therefore, current 
research is trying to focus on several topics regarding the application of synbiotic in 
vitro as below: 
1. To compare substrate affinity of 8 locally isolated wild type Bijidobacterium 
pseudocatenuIatum and 4 commercial Bz~dobacterium spp. towards 
oligofiuctose and inulin, 
